‘Voice Biomarker’ Shows Progress in CAD Risk Assessment

An occult voice 'biomarker' predicted CV-event risk in an angiography-referral cohort, with implications for screening, noninvasive risk stratification, and telemedicine, researchers say.
Medscape Medical News